Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Therapeutic Potential of Human Immune Globulin Intravenous (IGIV) in Patients With Cardiac-Associated Light Chain (AL) Amyloidosis

NCT00547365 is registered in ClinicalTrials.gov with University of Tennessee as lead sponsor.

NCT NCT00547365
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00547365 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Therapeutic Potential of Human Immune Globulin Intravenous (IGIV) in Patients With Cardiac-Associated Light Chain (AL) Amyloidosis
Lead sponsor
University of Tennessee
Phase
Phase 1/2
Overall status
Completed
Start date
October 31, 2007
Completion date
July 31, 2011
Enrollment
10 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

multiple myeloma, plasma cell neoplasm